These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9100811)

  • 21. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
    Case AS; Rocconi RP; Straughn JM; Wang W; Roark K; Waltman EE; Huh WK
    Obstet Gynecol; 2006 Dec; 108(6):1369-74. PubMed ID: 17138768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underwriting implications of carcinoma in situ of the cervix.
    Vecchione L
    J Insur Med; 1998; 30(4):226-30. PubMed ID: 10537927
    [No Abstract]   [Full Text] [Related]  

  • 26. Cervical cancer in a female-to-male trans-sexual.
    Driák D; Samudovský M
    Eur J Cancer; 2004 Jul; 40(11):1795. PubMed ID: 15251171
    [No Abstract]   [Full Text] [Related]  

  • 27. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of HPV-negative intestinal-type endocervical adenocarcinoma in situ with coexisting multifocal intestinal and gastric metaplasia.
    Talia KL; Cretney A; McCluggage WG
    Am J Surg Pathol; 2014 Feb; 38(2):289-91. PubMed ID: 24418863
    [No Abstract]   [Full Text] [Related]  

  • 29. HPyV6- and HPyV7-negative parakeratosis and dyskeratosis in squamous cell carcinoma in situ.
    Ko CJ; Wang A; Panse G; Lee EE; Wang RC; Whang PG; Bosenberg M; Damsky W
    J Cutan Pathol; 2021 Jul; 48(7):998-1000. PubMed ID: 33813761
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperchromatic crowded groups: pitfalls in pap smear diagnosis.
    Demay RM
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S36-43. PubMed ID: 11996167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsy of the cervix: a study of 200 cases. 1958.
    Malinconico LL; Tennant R; Wheeler ES
    Conn Med; 2008 Apr; 72(4):231-3. PubMed ID: 18478990
    [No Abstract]   [Full Text] [Related]  

  • 33. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
    Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides.
    Luzzatto L; van Haaften C; Boon ME
    Diagn Cytopathol; 2004 Jul; 31(1):5-9. PubMed ID: 15236256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of the mechanisms underlying the disparity between rate of residual endocervical adenocarcinoma in situ (AIS) in hysterectomy specimens and clinical failure rate following conservatively treated AIS.
    Goldstein NS
    Am J Clin Pathol; 2004 Oct; 122(4):540-5. PubMed ID: 15487451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenocarcinoma of the cervix uteri].
    Frank GA; Andreeva IuIu; Zavalishina LE; Petrov AN
    Arkh Patol; 1999; 61(5):61-5. PubMed ID: 10598265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix.
    Leung TW; Xue WC; Cheung AN; Khoo US; Ngan HY
    Gynecol Oncol; 2004 Mar; 92(3):866-72. PubMed ID: 14984954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of squamous intraepithelial lesions of indeterminate grade.
    Saab BA; Austin RM
    Am J Obstet Gynecol; 2008 Sep; 199(3):e13-4; author reply e14. PubMed ID: 18456230
    [No Abstract]   [Full Text] [Related]  

  • 40. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
    Dedecker F; Graesslin O; Bonneau S; Quéreux C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.